info@tenderlab.co.uk01707 240393
Read our Google reviewsFind us on Trustpilot

Official UK procurement notice

Open13 days remaining

NEYPPC-High Tech Homecare Medicines Service(2025)

Leeds Teaching Hospitals NHS Trust

A public procurement notice being reviewed against care-provider evidence

Opportunity overview

The North East & Yorkshire NHS Pharmaceutical Purchasing Consortium (NEYPPC) intend to establish a Framework Agreement for the provision of High Tech Homecare Medicines Services. The scope of this procurement will encompass all High Tech Homecare Medicines Services required by member Trusts within the NEY region, while also allowing access for non-member Trusts. Access for non-member Trusts will be available to any publicly funded entity, subject to prior approval from the Authority. The expectation is that the Framework will be multi-award, structured into the following Lots: Lot HT26-A: Unlicensed Compounded Desferrioxamine Homecare Medicines Services Lot HT26-B: Unlicensed Compounded Antimicrobial Homecare Medicines Services Lot HT26-C: Unlicensed Compounded Chemotherapy and Monoclonal Antibody Homecare Medicines Services Lot HT26-D: Other Unlicensed Compounded Homecare Medicines Services Lot HT26-E: Metabolic Disorders Homecare Medicines Services Medicines Lot HT26-F: Other Non-compounded High Tech Homecare Medicines Services

Lot 1 — HT26-A

Compounded Desferrioxamine Homecare Services

Estimated lot value including VAT: £49.2m

Award criterion: Commercial: 40%

Award criterion: Technical & Quality: 50%

Award criterion: Social Value: 10%

Suitable for small and medium-sized enterprises.

Suitable for voluntary, community and social enterprises.

Contract starts: 31 March 2027

Initial contract ends: 31 March 2029

Maximum term ends: 31 March 2031

Extension: optional 24 month extension

Lot HT26-B — HT26-B

Compounded Antimicrobial Homecare Services

Estimated lot value including VAT: £40.8m

Award criterion: Commercial: 40%

Award criterion: Technical & Quality: 50%

Award criterion: Social Value: 10%

Suitable for small and medium-sized enterprises.

Suitable for voluntary, community and social enterprises.

Contract starts: 31 March 2027

Initial contract ends: 31 March 2029

Maximum term ends: 31 March 2031

Extension: optional 24 month extension

Lot HT26-C — HT26-C

Unlicensed Compounded Chemotherapy and Monoclonal Antibody Homecare Medicines Services

Estimated lot value including VAT: £86.4m

Award criterion: Commercial: 40%

Award criterion: Technical & Quality: 50%

Award criterion: Social Value: 10%

Suitable for small and medium-sized enterprises.

Suitable for voluntary, community and social enterprises.

Contract starts: 31 March 2027

Initial contract ends: 31 March 2029

Maximum term ends: 31 March 2031

Extension: optional 24 month extension

Lot HT26-D — HT26-D

Other Unlicensed Compounded Homecare Medicines Services

Estimated lot value including VAT: £2.4m

Award criterion: Commercial: 40%

Award criterion: Technical & Quality: 50%

Award criterion: Social Value: 10%

Suitable for small and medium-sized enterprises.

Suitable for voluntary, community and social enterprises.

Contract starts: 31 March 2027

Initial contract ends: 31 March 2029

Maximum term ends: 31 March 2031

Extension: optional 24 month extension

Lot HT26-E — HT26-E

Metabolic Disorders Homecare Medicines Services

Estimated lot value including VAT: £14.4m

Award criterion: Commercial: 40%

Award criterion: Technical & Quality: 50%

Award criterion: Social Value: 10%

Suitable for small and medium-sized enterprises.

Suitable for voluntary, community and social enterprises.

Contract starts: 31 March 2027

Initial contract ends: 31 March 2029

Maximum term ends: 31 March 2031

Extension: optional 24 month extension

Lot HT26-F — HT26-F

Other Non-Compounded High Tech Homecare Medicines Services

Estimated lot value including VAT: £46.8m

Award criterion: Commercial: 40%

Award criterion: Technical & Quality: 50%

Award criterion: Social Value: 10%

Suitable for small and medium-sized enterprises.

Suitable for voluntary, community and social enterprises.

Contract starts: 31 March 2027

Initial contract ends: 31 March 2029

Maximum term ends: 31 March 2031

Extension: optional 24 month extension

Contracting authority

Leeds Teaching Hospitals NHS Trust Great George Street, Leeds, LS1 3EX, UKE42, United Kingdom Email: jennifer.bestford@nhs.net Website: https://www.leedsth.nhs.uk

Procurement timetable and procedure

Procedure: Open procedure

Clarification deadline: 26 October 2026 at 12:00 pm

Submission deadline: 4 November 2026 at 12:00 pm

Award decision expected by: 17 February 2027 at 11:59 pm

Electronic submissions: allowed

Submission language: EN

CPV Classification

33600000 — Pharmaceutical products; 85149000 — Pharmacy services

How to submit

The official Find a Tender notice directs suppliers to Atamis. The procurement documents, clarifications and response area are managed there.

Open Atamis ↗

TenderLab qualification first

Before we write, we establish whether the opportunity fits.

We examine the published participation conditions, service scope, geography, regulatory position, available evidence, mobilisation demands and commercial exposure with your team. We only confirm a full tender-writing engagement when the available information supports a responsible view that the provider meets the tender requirements.

If NEYPPC-High Tech Homecare Medicines Service(2025) is a credible fit, we can map the scored requirements, gather operational evidence and build the response around the buyer documents. The qualification check and any writing support do not guarantee an award; the contracting authority makes the final decision.

TenderLab Fit

Check whether this fits your organisation.

Start without creating an account. The tender title is carried into the eligibility and bid decision tools automatically.

Indicative TenderLab guidance only. We do not claim to have analysed procurement attachments unless you provide and confirm them.

TenderLab presents this information to support discovery. Dates, conditions, amendments, documents and submission instructions on the official record remain authoritative. Open official notice ↗